期刊论文详细信息
BMC Complementary and Alternative Medicine
Teng-Long-Bu-Zhong-Tang, a Chinese herbal formula, enhances anticancer effects of 5 - Fluorouracil in CT26 colon carcinoma
Yang Wu4  Meng-Meng Wei5  Xiu-Feng Shi2  Ke-Ping Shen1  Ling Xu5  Qin Du5  Hong-Mei An3  Bing Hu5  Shan Deng5 
[1] Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, PR China;Department of Pharmacy, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, PR China;Department of Science & Technology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, PR China;State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Keyuan Fourth Road, Chengdu, Sichuan 610072, PR China;Institute of Traditional Chinese Medicine in Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, PR China
关键词: Angiogenesis;    Cell senescence;    Apoptosis;    Chinese herbal formula;    Colon carcinoma;   
Others  :  1229857
DOI  :  10.1186/1472-6882-13-128
 received in 2013-01-29, accepted in 2013-05-28,  发布年份 2013
PDF
【 摘 要 】

Background

Colorectal cancer remains one of the leading causes of cancer death worldwide. Traditional Chinese Medicine (TCM) has played a positive role in colorectal cancer treatment. There is a great need to establish effective herbal formula for colorectal cancer treatment. Based on TCM principles and clinical practices, we have established an eight herbs composed formula for colorectal cancer treatment, which is Teng-Long-Bu-Zhong-Tang (TLBZT). We have demonstrated the anticancer effects of TLBZT against colorectal carcinoma in vitro. In present study, we evaluated the anticancer potential of TLBZT, used alone or in combination with low dose of 5-Fluorouracil (5-Fu), in CT26 colon carcinoma in vivo.

Methods

CT26 colon carcinoma was established in BALB/c mice and treated with TLBZT, 5-Fu, or TLBZT plus 5-Fu. The tumor volumes were observed. Apoptosis was detected by TUNEL assay. Caspases activities were detected by colorimetric assay. Cell senescence was indentified by senescence β-galactosidase staining. Gene expression and angiogenesis was observed by immunohistochemistry or western blot.

Results

TLBZT significantly inhibited CT26 colon carcinoma growth. TLBZT elicited apoptosis in CT26 colon carcinoma, accompanied by Caspase-3, 8, and 9 activation and PARP cleavage, and downregulation of XIAP and Survivin. TLBZT also induced cell senescence in CT26 colon carcinoma, with concomitant upregulation of p16 and p21 and downregulation of RB phosphorylation. In addition, angiogenesis and VEGF expression in CT26 colon carcinoma was significantly inhibited by TLBZT treatment. Furthermore, TLBZT significantly enhanced anticancer effects of 5-Fu in CT26 colon carcinoma.

Conclusions

TLBZT exhibited significantly anticancer effect, and enhanced the effects of 5-Fu in CT26 colon carcinoma, which may correlate with induction of apoptosis and cell senescence, and angiogenesis inhibition. The present study provides new insight into TCM approaches for colon cancer treatment that are worth of further study.

【 授权许可】

   
2013 Deng et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20151103020044995.pdf 2727KB PDF download
Figure 7. 132KB Image download
Figure 6. 66KB Image download
Figure 5. 40KB Image download
108KB Image download
Figure 3. 54KB Image download
Figure 2. 81KB Image download
Figure 1. 27KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】
  • [1]Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
  • [2]Storli KE, Søndenaa K, Bukholm IR, Nesvik I, Bru T, Furnes B, Hjelmeland B, Iversen KB, Eide GE: Overall survival after resection for colon cancer in a national cohort study was adversely affected by TNM stage, lymph node ratio, gender, and old age. Int J Colorectal Dis 2011, 26(10):1299-1307.
  • [3]Davies JM, Goldberg RM: Treatment of metastatic colorectal cancer. Semin Oncol 2011, 38(4):552-560.
  • [4]Deng S, Hu B, An HM: Traditional Chinese Medicinal Syndromes and Treatment in Colorectal Cancer. J Cancer Ther 2012, 3(6):888-897.
  • [5]Hu B, Du Q, Shen KP, Xu L: Principles and Scientific Basis of Traditional Chinese Medicine in Cancer Treatment. J Bioanal Biomed 2012, S6:005.
  • [6]Deng S, Hu B, Shen KP: Pathogenesis and treatment of colorectal cancer in Traditional Chinese Medicine. World Sci Technol Mod Trad Chinese Med Mater Med 2012, 14(4):1858-1862. Chinese
  • [7]Wang XR, Yuan XB, Li P, Gao L: The TCM Syndrome Distribution in Colorectal Cancer. J Changchun Coll Trad Chinese Med 2011, 2(3):377-379. Chinese
  • [8]Hu B, An HM, Shen KP, Du Q: Effects of Tenglong Buzhong Decoction on proliferation and apoptosis of human colon carcinoma cell line LS-174T. J Chinese Integr Med 2010, 8(6):575-580. Chinese
  • [9]Hu B, An HM, Shen KP, Du Q: Senescence-inducing effects of Chinese herbal medicine Tenglong Buzhong Decoction on human colon carcinoma LS-174T cells and the mechanism. J Chinese Integr Med 2010, 8(11):1048-1052. Chinese
  • [10]Wong RS: Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 2011, 26(30):87.
  • [11]Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC: Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371(6495):346-347.
  • [12]Xiang G, Wen X, Wang H, Chen K, Liu H: Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis. J Surg Oncol 2009, 100(8):708-712.
  • [13]Hernandez JM, Farma JM, Coppola D, Hakam A, Fulp WJ, Chen DT, Siegel EM, Yeatman TJ, Shibata D: Expression of the antiapoptotic protein survivin in colon cancer. Clin Colorectal Cancer 2011, 10(3):188-193.
  • [14]Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995, 92(20):9363-9367.
  • [15]Roninson IB: Tumor cell senescence in cancer treatment. Cancer Res 2003, 63(11):2705-2715.
  • [16]Zhang NN, Bu P, Zhu HH, Shen WG: Inhibitory effects of Scutellaria barbatae D. Don on tumor angiogenesis and its mechanism. Chinese J cancer 2005, 24(12):1459-1463. Chinese
  • [17]Wei L, Lin J, Xu W, Cai Q, Shen A, Hong Z, Peng J: Scutellaria barbata D. Don Inhibits Tumor Angiogenesis via Suppression of Hedgehog Pathway in a Mouse Model of Colorectal Cancer. Int J Mol Sci 2012, 13(8):9419-9430.
  • [18]Elluru SR, Duong Van Huyen JP, Delignat S, Prost F, Heudes D, Kazatchkine MD, Friboulet A, Kaveri SV: Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity. Anticancer Res 2009, 29(8):2945-2950.
  • [19]Van Huyen JP, Bayry J, Delignat S, Gaston AT, Michel O, Bruneval P, Kazatchkine MD, Nicoletti A, Kaveri SV: Induction of apoptosis of endothelial cells by Viscum album: a role for anti-tumoral properties of mistletoe lectins. Mol Med 2002, 8(10):600-6.
  • [20]Kuzu I, Bicknell R, Harris AL, Jones M, Gatter KC, Mason DY: Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol 1992, 45(2):143-148.
  • [21]Chetty C, Lakka SS, Bhoopathi P, Kunigal S, Geiss R, Rao JS: Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer. Cancer Res 2008, 68(12):4736-4745.
  • [22]Hsieh HY, Chiu PH, Wang SC: Epigenetics in traditional chinese pharmacy: a bioinformatic study at pharmacopoeia scale. Evid Based Complement Alternat Med 2011, 201(1):816714.
  • [23]Zuo LL, Wang ZY, Fan ZL, Tian SQ, Liu JR: Evaluation of Antioxidant and Antiproliferative Properties of Three Actinidia (Actinidia kolomikta, Actinidia arguta, Actinidia chinensis) Extracts in Vitro. Int J Mol Sci 2012, 13(5):5506-5518.
  • [24]Chen YJ, Shi RJ: Ethanol extract from radix of Actinidia chinensis inhibits cell proliferation and induces apoptosis in human colon carcinoma cell line LoVo. World Chinese J Digestol 2012, 20(18):1657-1661. Chinese
  • [25]Ding X, Zhu FS, Li M, Gao SG: Induction of apoptosis in human hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L. J Ethnopharmacol 2012, 139(2):599-604.
  • [26]Ji YB, Gao SY: Study on Mitochondrion Pathway of the Apoptosis of HepG2 Induced by Solanine. Chinese Pharm J 2008, 43(3):272-275.
  • [27]Ji YB, Yuan HC, Gao SY, Sun HB: Material basis of cytotoxicity in polysaccharide from Solanum nigrum. Chinese Trad Herbal Drugs 2011, 42(11):2275-2278. Chinese
  • [28]Nawab A, Thakur VS, Yunus M, Ali Mahdi A, Gupta S: Selective cell cycle arrest and induction of apoptosis in human prostate cancer cells by a polyphenol-rich extract of Solanum nigrum. Int J Mol Med 2012, 29(2):277-284.
  • [29]Peng B, Hu Q, Liu X, Wang L, Chang Q, Li J, Tang J, Wang N, Wang Y: Duchesnea phenolic fraction inhibits in vitro and in vivo growth of cervical cancer through induction of apoptosis and cell cycle arrest. Exp Biol Med (Maywood) 2009, 234(1):74-83.
  • [30]Peng B, Chang Q, Wang L, Hu Q, Wang Y, Tang J, Liu X: Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis. Gynecol Onco 2008, 108(1):173-181.
  • [31]Zhu QJ, Zheng GJ, Zhang D: Study on antitumor effect and mechanism of extract of Atractylodes macrocephala Koidz. J Shandong Univ Trad Chinese Med 2006, 30(1):69-71. Chinese
  • [32]Kikuchi T, Uchiyama E, Ukiya M, Tabata K, Kimura Y, Suzuki T, Akihisa T: Cytotoxic and apoptosis-inducing activities of triterpene acids from Poria cocos. J Nat Prod 2011, 74(2):137-144.
  • [33]Gapter L, Wang Z, Glinski J, Ng KY: Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos. Biochem Biophys Res Commun 2005, 332(4):1153-1161.
  • [34]Lu Y, Li CS, Dong Q: Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes. J Exp Clin Cancer Res 2008, 27:31. BioMed Central Full Text
  • [35]Chung CP, Hsu CY, Lin JH, Kuo YH, Chiang W, Lin YL: Antiproliferative lactams and spiroenone from adlay bran in human breast cancer cell lines. J Agric Food Chem 2011, 59(4):1185-94.
  • [36]Goh D, Lee YH, Ong ES: Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines. LoVo J Agric Food Chem 2005, 53(21):8197-8204.
  • [37]Wang SM, Ye M, Ni ZM: Effect of mistletoe lectins on proliferation and apoptosis in HT-29 colon cancer cell. Chinese J Clin Pharmacol Ther 2007, 12(9):1028-1031. Chinese
  • [38]Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
  • [39]Brown JM, Attardi LD: The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 2005, 5:231.
  • [40]Miura K, Fujibuchi W, Ishida K, Naitoh T, Ogawa H, Ando T, Yazaki N, Watanabe K, Haneda S, Shibata C, Sasaki I: Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer. Surg Today 2011, 41(2):175-182.
  • [41]Connolly K, Mitter R, Muir M, Jodrell D, Guichard S: Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro. Cancer Chemother Pharmacol 2009, 64(2):307-316.
  • [42]Cai M, Wang GB, Tao KX, Cai CX: Enhanced chemotherapy sensitivity of human colon cancer cells to 5-fluorouracil by siRNA recombinant expression vector targeting survivin gene. Chin Med Sci J 2009, 24(2):97-101.
  • [43]Chiantore MV, Vannucchi S, Mangino G, Percario ZA, Affabris E, Fiorucci G, Romeo G: Senescence and cell death pathways and their role in cancer therapeutic outcome. Curr Med Chem 2009, 16(3):287-300.
  • [44]Gewirtz DA, Holt SE, Elmore LW: Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 2008, 76(8):947-957.
  • [45]Nardella C, Clohessy JG, Alimonti A, Pandolfi PP: Pro-senescence therapy for cancer treatment. Nat Rev Cancer 2011, 11(7):503-511.
  • [46]Chang UM, Li CH, Lin LI, Huang CP, Kan LS, Lin SB: Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cells. Life Sci 2006, 79(12):1129-1139.
  • [47]Peng CC, Chen KC, Peng RY, Chyau CC, Su CH, Hsieh-Li HM: Antrodia camphorata extract induces replicative senescence in superficial TCC, and inhibits the absolute migration capability in invasive bladder carcinoma cells. J Ethnopharmacol 2007, 109(1):93-103.
  • [48]Hu B, An HM, Shen KP, Xu L, DU Q, Deng S, Wu Y: Liver Yin deficiency tonifying herbal extract induces apoptosis and cell senescence in Bel-7402 human hepatocarcinoma cells. Exp Ther Med 2012, 3(1):80-86.
  • [49]Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 1971, 285(21):1182-1186.
  • [50]Rapisarda A, Melillo G: Role of the VEGF/VEGFR axis in cancer biology and therapy. Adv Cancer Res 2012, 114:237-267.
  • [51]Allavena P, Sica A, Garlanda C, Mantovani A: The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 2008, 222:155-161.
  • [52]Zhu WJ, Yu DH, Zhao M, Lin MG, Lu Q, Wang QW, Guan YY, Li GX, Luan X, Yang YF, Qin XM, Fang C, Yang GH, Chen HZ: Antiangiogenic triterpenes isolated from Chinese herbal medicine Actinidia Chinensis Planch. Anticancer Agents Med Chem 2012, 13(2):195-198.
  • [53]Xu Y, Pan RL, Chang Q, Qin M, Liu Y, Tang JT: Experimental study of Solanum nigrum on inhibiting angiogenesis in chick chorioallantoic membrane. China J Chinese Mater Med 2008, 33(5):549-552. Chinese
  • [54]Xu Y, Pan RL, Chang Q, Tang JT, Liu Y: Inhibitory effects of Duchesnea indica (andr) Focke on angiogenesis in chick chorioallantoic membrane. Pharmacol Clin Chinese Mater Med 2008, 24(3):65-67. Chinese
  文献评价指标  
  下载次数:51次 浏览次数:10次